(16)   Ungard R, Singh G. Oxidative stress and glutamate release in glioma. In: Ghosh A, editor. Glioma - Exploring Its Biology and Practical Relevance.Rijeka: Intech; 2011. p. 451-65.

(15)   Szabo KA, Singh G. Roles of immune-cell-derived matrix metalloproteinases. In: Singh G, Rabbani S, editors. Bone Metastasis: Experimental and Clinical Therapeutics.Totowa, N.J.: Humana Press Inc.; 2005. p. 87-106.

(14)   Seidlitz E, Saikali Z, Singh G. Use of tetracyclines for bone metastases. In: Singh G, Rabbani S, editors. Bone Metastasis: Experimental and Clinical Therapeutics.Totowa, N.J.: Humana Press Inc.; 2005. p. 295-305.

 

(13)   Persad S, Singh G. Cell adhesion molecules in tumor metastasis. In: Singh G, Rabbani S, editors. Bone Metastasis: Experimental and Clinical Therapeutics.Totowa, N.J.: Humana Press Inc.; 2005. p. 133-46.

 

(12)   McDuffee L, Colterjohn N, Singh G. Bone metastasis and pathological fractures: bone tissue engineering as a novel therapy. In: Singh G, Rabbani S, editors. Bone Metastasis: Experimental and Clinical Therapeutics.Totowa, N.J.: Humana Press Inc.; 2005. p. 229-42.

 

(11)   Giles ED, Singh G. Role of TGF-b and IGF in tumour progression and bone metastasis. In: Singh G, Rabbani S, editors. Bone Metastasis: Experimental and Clinical Therapeutics.Totowa, N.J.: Humana Press Inc.; 2005. p. 59-74.

 

(10)   Vukmirovic-Popovic S, Seidlitz E, Orr FW, Singh G. Comparative morphometric study on bone remodeling in human specimens and in experimental models of metastatic bone disease. In: Singh G, Orr FW, editors. Bone Metastasis and Molecular Mechanisms: Pathophysiology.Dordrecht: Kluwer Academic Publishers; 2004. p. 31-48.

 

(9)   Singh S, Singh G. Potential therapeutic targets for bone metastasis. In: Singh G, Orr FW, editors. Bone Metastasis and Molecular Mechanisms: Pathophysiology.Dordrecht: Kluwer Academic Publishers; 2004. p. 187-210.

 

(8)   Duivenvoorden WCM, Singh G. Role of matrix metalloproteinases in bone metastasis from human breast and prostate cancer.  In: Singh G, Orr FW, editors. Bone Metastasis and Molecular Mechanisms: Pathophysiology.Dordrecht: Kluwer Academic Publishers; 2004. p. 241-76.

 

(7)   Singh G. Featured Scientists. In: Ritter B, Adam-Carr C, Fraser D, editors. Nelson Biology 11.Scarborough: Nelson Education; 2002. p. -660.

 

(6)   Preston T, Singh G. Mitochondrial signalling and cancer. In: Mattson MP, editor. Intraorganellar signalling in age related disease. v.7 ed.  Oxford: Elsevier Science; 2001. p. 103-30.

 

(5)   Sanchez-Sweatman O, Khokha R, Singh G. Mechanisms of cancer cell-mediated osteolysis. In: Orr FW, Singh G, editors. Bone Metastasis: Mechanisms and Pathophysiology.Norwell, MA: R.G. Landes/Chapman Hall; 1996. p. 123-32.

 

(4)   Kostenuik PJ, Singh G, Orr FW. Potential role for adhesion in pathogenesis of bone metastasis. In: Orr FW, Singh G, editors. Bone Metastasis: Mechanisms and Pathophysiology.Norwell, MA: R.G. Landes/Chapman Hall; 1996. p. 59-68.

 

(3)   Sharkey S, Singh G, Moorehead R, Wilson B. Characterization of RIF cells resistant to Photofrin-photodynamic therapy in vitro. In: Spinelli P, Dal Fante M, Marchesini R, editors. Photodynamic therapy and biomedical lasers. 1 ed.  Amsterdam: Elsevier; 1992. p. 727-31.

 

(2)   Renton KW, Singh G. Viral infection and xenobiotic metabolism. In: Mullen PW, editor. NATO ASI (Advanced Science Institute). 2 ed.  New York: Springer-Verlag; 1984. p. 97-102.

 

(1)   Hawke RL, Raynor L, Singh G, Neims AH. Differences between kidney and liver in the regulation of microsomal testosteron hydroxylase activities in inbred mice. In: Rydström J, Montelius J, Bengtsson M, editors. Extra-hepatic Drug Metabolism and Chemical Carcinogenesis.Amsterdam: Elsevier; 1983. p. 23-4.